Allison Y. Tso

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).

Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).

Journal: Leukemia & lymphoma

Published: December 16, 2025

Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis.

Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis.

Journal: Blood advances

Published: December 01, 2025

AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management.

AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management.

Journal: Annals of the Academy of Medicine, Singapore

Published: June 26, 2024

Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers.

Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers.

Journal: PharmacoEconomics - open

Published: June 03, 2024

Daratumumab-Based Therapeutic Approaches and Clinical Outcomes in Multiple Myeloma and other Plasma Cell Dyscrasias: Insights from a Nationwide Real-World Chart Review Study.

Daratumumab-Based Therapeutic Approaches and Clinical Outcomes in Multiple Myeloma and other Plasma Cell Dyscrasias: Insights from a Nationwide Real-World Chart Review Study.

Journal: Clinical hematology international

Published: June 01, 2024

Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learnt.

Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learnt.

Journal: Singapore medical journal

Published: April 08, 2024

Real-world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore.

Real-world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore.

Journal: EJHaem

Published: August 20, 2023

A Retrospective Review of Secondary Hemophagocytic Lymphohistiocytosis (HLH) and Dengue-associated HLH from a Teaching Hospital in Singapore.

A Retrospective Review of Secondary Hemophagocytic Lymphohistiocytosis (HLH) and Dengue-associated HLH from a Teaching Hospital in Singapore.

Journal: Clinical hematology international

Published: July 15, 2023

Tolerability of Daratumumab Amongst Asian Patients with Plasma Cell Dyscrasias - A Single Centre Experience.

Tolerability of Daratumumab Amongst Asian Patients with Plasma Cell Dyscrasias - A Single Centre Experience.

Journal: Clinical hematology international

Published: July 09, 2023

Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?

Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?

Journal: Seminars in thrombosis and hemostasis

Published: June 27, 2022

Single-agent daratumumab for refractory POEMS syndrome.

Single-agent daratumumab for refractory POEMS syndrome.

Journal: American journal of hematology

Published: January 17, 2022

On-pack recycling label in cosmeceutical products in dermatology.

On-pack recycling label in cosmeceutical products in dermatology.

Journal: Clinical and experimental dermatology

Published: August 07, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026